https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-11-30 / Vet World 2024 Nov;17(11):2688-2693
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-11-30 / Vet World 2024 Nov;17(11):2688-26932024-11-30 00:00:002024-11-30 00:00:00The oncolytic effect of Newcastle disease virus attenuated AMHA1 strain against digestive system tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-21 / Expert Opin Biol Ther 2024 Apr;24(4):269-284
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-21 / Expert Opin Biol Ther 2024 Apr;24(4):269-2842024-04-21 00:00:002024-04-21 00:00:00The future of cancer vaccines against colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-10-02 / Front Immunol 2023;14:1241949
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-10-02 / Front Immunol 2023;14:12419492023-10-02 00:00:002023-10-02 00:00:00Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-16 / Biochem Biophys Res Commun 2023 Apr;653:106-114
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-16 / Biochem Biophys Res Commun 2023 Apr;653:106-1142023-02-16 00:00:002023-02-16 00:00:00Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-09-09 / Cancer Immunol Immunother 2023 Apr;72(4):827-840
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-09-09 / Cancer Immunol Immunother 2023 Apr;72(4):827-8402022-09-09 00:00:002024-11-12 09:18:52A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-01 / Int Immunopharmacol 2022 Sep;110:109016
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-01 / Int Immunopharmacol 2022 Sep;110:1090162022-08-01 00:00:002022-08-01 00:00:00Triiodothyronine-stimulated dendritic cell vaccination boosts antitumor immunity against murine colon cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-07 / Cancer Res Commun 2022 Jul;2(7):602-615
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-07 / Cancer Res Commun 2022 Jul;2(7):602-6152022-07-07 00:00:002022-07-07 00:00:00Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-04-05 / PLoS One 2022;17(4):e0264896
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-04-05 / PLoS One 2022;17(4):e02648962022-04-05 00:00:002022-04-05 00:00:00Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-03-01 / Cancers (Basel) 2022 Mar;14(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-03-01 / Cancers (Basel) 2022 Mar;14(5)2022-03-01 00:00:002022-03-01 00:00:00Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-04 / Gene Ther 2023 Feb;30(1-2):64-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-04 / Gene Ther 2023 Feb;30(1-2):64-742021-10-04 00:00:002023-05-30 16:42:19Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy
